Edgestream Partners L.P. Acquires 6,233 Shares of Chemed Corporation $CHE

Edgestream Partners L.P. increased its stake in shares of Chemed Corporation (NYSE:CHE) by 435.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,665 shares of the company’s stock after buying an additional 6,233 shares during the period. Edgestream Partners L.P. owned 0.05% of Chemed worth $3,732,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Cetera Investment Advisers lifted its position in shares of Chemed by 6.2% during the first quarter. Cetera Investment Advisers now owns 1,715 shares of the company’s stock worth $1,056,000 after purchasing an additional 100 shares in the last quarter. LPL Financial LLC raised its position in Chemed by 12.7% in the 1st quarter. LPL Financial LLC now owns 10,527 shares of the company’s stock worth $6,477,000 after purchasing an additional 1,185 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Chemed by 9.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 148,920 shares of the company’s stock worth $91,633,000 after buying an additional 12,738 shares in the last quarter. Ontario Teachers Pension Plan Board lifted its holdings in Chemed by 258.4% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 5,992 shares of the company’s stock worth $3,687,000 after buying an additional 4,320 shares in the last quarter. Finally, Deutsche Bank AG boosted its position in Chemed by 424.0% in the 1st quarter. Deutsche Bank AG now owns 11,544 shares of the company’s stock valued at $7,103,000 after buying an additional 9,341 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CHE. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Royal Bank Of Canada dropped their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and upped their target price for the company from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Finally, Bank of America dropped their price target on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $574.25.

Chemed Trading Up 0.5%

Shares of CHE opened at $431.62 on Thursday. The stock has a market cap of $6.11 billion, a P/E ratio of 22.83, a price-to-earnings-growth ratio of 2.44 and a beta of 0.46. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60. The stock’s 50-day moving average price is $439.24 and its two-hundred day moving average price is $471.22.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The company had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Monday, November 17th will be issued a $0.60 dividend. The ex-dividend date is Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 12.69%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 3,000 shares of the business’s stock in a transaction on Friday, September 26th. The shares were sold at an average price of $461.28, for a total value of $1,383,840.00. Following the completion of the transaction, the chief executive officer owned 96,197 shares of the company’s stock, valued at $44,373,752.16. The trade was a 3.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Patrick P. Grace sold 150 shares of the company’s stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director owned 3,397 shares of the company’s stock, valued at approximately $1,574,135.83. This represents a 4.23% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 5,150 shares of company stock worth $2,328,449. Insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.